Julien Lalut
Caen, 14000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: September 20, 2024
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: August 24, 2020
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease.
Journal: Scientific reports
Published: July 27, 2019
Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: July 18, 2019
Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase.
Journal: European journal of medicinal chemistry
Published: October 02, 2018
Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment.
Journal: Future medicinal chemistry
Published: May 16, 2017
Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography.
Journal: European journal of medicinal chemistry
Published: March 03, 2016
Synthesis of C3-arylated-3-deazauridine derivatives with potent anti-HSV-1 activities.
Journal: Bioorganic & medicinal chemistry letters
Published: September 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026